Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Syros Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 58 | +11 |
| Shares | 12.1M | 1.30M | 19.2M | +8.41M (+77.6%) |
| Value | $47.9M | $5.12M | $146.8M | +$104.0M (+242.9%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 1,471,771 | $11.5M | 0.03% |
| Blue Owl Capital Holdings LP | 1,493,252 | $8.46M | 2.02% |
| Opaleye Management Inc. | 359,370 | $2.80M | 0.75% |
| UBS Oconnor LLC | 130,000 | $1.01M | 0.03% |
| Tang Capital Management LLC | 85,031 | $662.4K | 0.06% |
| EAM Investors, LLC | 84,002 | $654.4K | 0.12% |
| Two Sigma Investments, LP | 54,654 | $425.8K | 0.00% |
| 683 Capital Management, LLC | 36,444 | $283.9K | 0.03% |
| Marshall Wace, LLP | 24,818 | $193.3K | 0.00% |
| Jane Street Group, LLC | 21,135 | $164.6K | 0.00% |
| XTX Topco Ltd | 11,006 | $85.7K | 0.02% |
| Y-Intercept (Hong Kong) Ltd | 10,512 | $81.9K | 0.01% |
| Integrated Wealth Concepts LLC | 10,000 | $77.9K | 0.00% |
| Citadel Advisors LLC | 6,180 | $48.1K | 0.00% |
| PSI Advisors, LLC | 13 | $101 | 0.00% |
| Steward Partners Investment Advisory, LLC | 8 | $62 | 0.00% |
Sold out (5)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Shay Capital LLC | 23,776 | $93.9K |
| UBS Group AG | 1,093 | $4.32K |
| FMR LLC | 346 | $1.37K |
| Farther Finance Advisors, LLC | 20 | $79 |
| CWM, LLC | 18 | $0 |
Not filed for Q4 2023 yet (1)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| CHI Advisors LLC | 1,299,359 | $5.12M |